Major Earnings Expected After the Close Tuesday: CoreWeave, Inovio Pharmaceuticals, Luminar Technologies, and More

Major earnings expected after the close on Tuesday include CoreWeave (CRWV), Inovio Pharmaceuticals (INO), Luminar Technologies (LAZR), Lumentum Holdings (LITE), and Gladstone Investment Corporation (GAIN). Additional earnings scheduled for release after Tuesday's close include AOIFF, CAVA, CLPT, EC, ECO, HRB, HYLN, IDN, IZEA, LCTX, LGMK, NVGS, PEYUF, PLBY, PRTS, PXLW, QUIK, REKR, RGTI, SND, SPRO, TBPH, and ZVRA.

Several major companies are scheduled to release their earnings reports after the market close on Tuesday, August 12, 2025. Investors and financial professionals are keeping a close eye on the following companies: CoreWeave (CRWV), Inovio Pharmaceuticals (INO), Luminar Technologies (LAZR), Lumentum Holdings (LITE), and Gladstone Investment Corporation (GAIN). Additionally, earnings for AOIFF, CAVA, CLPT, EC, ECO, HRB, HYLN, IDN, IZEA, LCTX, LGMK, NVGS, PEYUF, PLBY, PRTS, PXLW, QUIK, REKR, RGTI, SND, SPRO, TBPH, and ZVRA are also expected to be released after Tuesday's close.

Luminar Technologies (LAZR)

Luminar Technologies, an automotive technology company, is one of the key companies set to release its Q2 2025 earnings on Tuesday. The company has a market capitalization of $127.98 million and is expected to report earnings of ($1.19) per share and revenue of $17.27 million for the quarter [1]. Analysts maintain a consensus rating of "Hold" for LAZR, with a significant drop in target price from Goldman Sachs, now at $2.00.

The company's stock has declined 2.2%, currently trading at $2.73. Luminar Technologies' Q1 revenue declined 10% year-over-year to $18.9M with a non-GAAP gross loss of $6.4M. The company is consolidating its product portfolio around a unified Halo platform, standardizing core LiDAR technology to streamline development and reduce costs across OEM partnerships [2]. The appointment of new CEO Paul Ritchie, who brings a wealth of experience from Nuance, adds a layer of uncertainty for investors.

Inovio Pharmaceuticals (INO)

Inovio Pharmaceuticals is another company with upcoming earnings. The biotechnology company is expected to report its Q2 2025 earnings on Tuesday. INO has been in the spotlight due to its COVID-19 vaccine candidate, INO-4800, which has shown promising results in clinical trials. The company's stock has been volatile, with analysts predicting varying outcomes based on the latest clinical data.

Lumentum Holdings (LITE)

Lumentum Holdings, a leading provider of photonics products, is also scheduled to release its Q2 2025 earnings on Tuesday. The company has been focusing on expanding its market presence in the data center and automotive industries. Lumentum's stock has been relatively stable, with analysts expecting modest growth in revenue and earnings for the quarter.

Gladstone Investment Corporation (GAIN)

Gladstone Investment Corporation, a closed-end investment company, is expected to report its Q2 2025 earnings on Tuesday. GAIN invests in a diversified portfolio of companies across various industries. The company's stock has been performing well, with analysts expecting continued growth in its investment portfolio.

Conclusion

Investors and financial professionals will be closely watching the earnings reports from these key companies on Tuesday, August 12, 2025. The market's reaction to these earnings reports will provide valuable insights into the companies' performance and future prospects. As always, it is essential to stay informed and make investment decisions based on thorough analysis and understanding of the underlying fundamentals.

References:

[1] https://www.marketbeat.com/instant-alerts/luminar-technologies-lazr-to-release-quarterly-earnings-on-tuesday-2025-08-05/
[2] https://www.marketbeat.com/earnings/reports/2025-5-14-luminar-technologies-inc-stock/